Autopsy report · NCT01921998

Development of a Biomarker Directed Strategy to Ameliorate Common Toxicities From Conventional Chemotherapy

“Trial has been suspended due to lack of resource and staff”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Suspended: paused, and may or may not restart.
• 50 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Sponsor

The Christie NHS Foundation Trust

Sponsor type

University, hospital or other

Conditions

Lymphoma; Sarcoma

Interventions

Biomarker and health economics

Participants

50 (planned, not actual)

Sites

1

Countries

United Kingdom

Trials that died the same way

• Department of Defense PTSD Adaptive Platform Trial - Master Protocol
  “The trial has been temporarily suspended due to administrative issues” (88% match in meaning)
• The Dose Finding Study of DAOIB Added to tDCS for AD
  “The trial was suspended due to the budget issue” (81% match in meaning)
• Anti-TRBC1 CAR-T Cell Therapy in Patients With TRBC1 Positive T Cell Malignancies
  “The trial was suspended due to the inability to enroll qualified participants” (80% match in meaning)
• Autologous Stem Cells in Pediatric Patients With Dilated Cardiomyopathy
  “Suspended because the lack of patients among the time this clinical trial was running.” (74% match in meaning)
• A Trial in Painful Diabetic Peripheral Neuropathy With GRT3983Y
  “Trial was stopped due to difficult enrolment” (73% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.